Fresenius Medical Care Announces Publication of Multinational Real-World Evidence Study on High-Volume Hemodiafiltration (IN BRIEF) Fresenius Medical Care has announced the publication of a large multinational real-world evidence study in the Journal of the American Society of Nephrology (JASN) reporting that hemodiafiltration (HDF) was associated with a 28% lower relative risk of all-cause mortality compared with conventional high-flux hemodial…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.